Volume 5, Issue 2, Summer 2026

Articles

• 

  Relapsed Follicular Lymphoma in 2026: Evolving Treatment Strategies in the Canadian Context

  Mary-Margaret Keating, MD, FRCPC

  5-12

  • PDF
• 

  Sequencing Therapies in Peripheral T-Cell Lymphoma

  Danyal Ladha, MD, Anca Prica, MD

  13-25

  • PDF
• 

  Front-Line Management of Mantle Cell Lymphoma in Canada: A Practical, Risk-Adapted Approach

  Justin Desroches, MD, FRCPC, Diego Villa, MD, MPH, FRCPC

  26-36

  • PDF
• 

  Post CAR T-Cell Therapy Care: Monitoring and Toxicity Management

  Justine Lai, PhD, Peng Wang, MD, PhD, FRCPC, Michael P. Chu, MD, FRCPC

  37-46

  • PDF
• 

  Front-line DLBCL Therapies in Canada in 2026: Biology Matters

  Jia Li Liu, MD, Nathalie A. Johnson, MD, PhD, FRCPC

  47-58

  • PDF